8 European Projects Found
Searched on 125080 European Projects
FINISHED
Breast Cancer Risk after Diagnostic Gene Sequencing (BRIDGES) (BRIDGES)
Start date: Sep 1, 2015, End date: Aug 31, 2020,
Breast cancer affects more than 360,000 women per year in the EU and causes more than 90,000 deaths. Identification of women at high risk of the disease can lead to disease prevention through intensive screening, chemoprevention or prophylactic surgery. Breast cancer risk is determined by a combination of genetic and lifestyle risk factors. The advent of next generation sequencing has opened up th ...
Read Project
20
Partners Participants
FINISHED
Virus-X: Viral Metagenomics for Innovation Value (Virus-X)
Start date: Apr 1, 2016, End date: Mar 31, 2020,
Biological sequence diversity in nowhere as apparent as in the vast sequence space of viral genomes. The Virus-X project will specifically explore the outer realms of this diversity by targeting the virosphere of selected microbial ecosystems and investigate the encoded functional variety of viral gene products. The project is driven by the expected large innovation value and unique properties of ...
Read Project
15
Partners Participants
FINISHED
Developing a validated technology platform for the application of oxygen dependent enzymes in synthesis and transformation of alcohols (BIOOX)
Start date: Oct 1, 2013, End date: Sep 30, 2017,
Currently the aerobic bio-catalytic oxidation reaction is the one that would have the biggest impact on the future uptake of industrial biotechnology in Europe. Chemical oxidation is both hazardous and has high environment impacts. Many oxidative bio-catalytic reactions and transformations have been identified in academic laboratories but only a very small number have been applied by industry to o ...
Read Project
12
Partners Participants
FINISHED
Integrated European –omics research project for diagnosis and therapy in rare neuromuscular and neurodegenerative diseases (Neuromics)
Start date: Oct 1, 2012, End date: Sep 30, 2017,
Neurodegenerative (ND) and neuromuscular (NM) disease is one of the most frequent classes of rare diseases, affecting life and mobility of 500,000 patients in Europe and millions of their caregivers, family members and employers. This NEUROMICS project brings together the leading research groups in Europe, five highly innovative SMEs and relevant oversea experts using the most sophisticated Omics ...
Read Project
20
Partners Participants
FINISHED
Sucrose Synthase as Cost-Effective Mediator of Glycosylation Reactions (SUSY)
Start date: Sep 1, 2013, End date: Aug 31, 2017,
Glycosyl transferases (GT) are extremely efficient biocatalysts that can be used for the synthesis of special carbohydrates and glycoconjugates. Famous examples of such products include human milk oligosaccharides that serve as prebiotics, and glycosides of flavonoids with improved stability and solubility. Unfortunately, the large-scale application of GT has been hampered by their low operational ...
Read Project
8
Partners Participants
FINISHED
Marine Microbial Biodiversity, Bioinformatics and Biotechnology (MICRO B3)
Start date: Jan 1, 2012, End date: Dec 31, 2015,
Micro B3 will develop innovative bioinformatic approaches and a legal framework to make large-scale data on marine viral, bacteria; archaeal and protists genomes and metagenomes accessible for marine ecosystems biology and to define new targets for biotechnological applications. Micro B3 will build upon a highly interdisciplinary consortium of 32 academic and industrial partners comprising world-l ...
Read Project
32
Partners Participants
FINISHED
An interactive protein engineering portal with validated software and database facilities (NEWPROT)
Start date: Dec 1, 2011, End date: Nov 30, 2015,
Two academic groups and eight SMEs who all work on different aspects of protein engineering will collaborate and produce a website that will consist of a portal with an embedded workbench to provide users a self-service system for in silico protein engineering. This interactive self-service portal will give users access to a wide variety of protein engineering facilities and information systems, a ...
Read Project
10
Partners Participants
FINISHED
The discovery, development and demonstration of biocatalysts for use in the industrial synthesis of chiral chemicals (KYROBIO)
Start date: Dec 1, 2011, End date: Nov 30, 2015,
The objective of KYROBIO project is to broaden the toolbox of single enantiomer chiral chemicals that are produced by industry in Europe using biotechnological routes. The main target is applications of lyase enzymes to selectively synthesize molecules with multiple chiral centres applying enzymatic carbon-carbon and carbon-nitrogen bond formation as the key technical platforms. We will then apply ...
Read Project
